Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases
about
Pharmacologic management of advanced cervical cancer: antiangiogenesis therapy and immunotherapeutic considerationsImproved survival with bevacizumab in advanced cervical cancerTargeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth.Cdc6 contributes to abrogating the G1 checkpoint under hypoxic conditions in HPV E7 expressing cells.Productive replication of human papillomavirus 31 requires DNA repair factor Nbs1.Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle.The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation.Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation.Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoproteinHEXIM1 down-regulates hypoxia-inducible factor-1α protein stability.Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.Lung Cancer and Human Papilloma Viruses (HPVs): Examining the Molecular EvidenceTranscription factor networks as targets for therapeutic intervention of cancer: the breast cancer paradigm.Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor.Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.Breaking down the evidence for bevacizumab in advanced cervical cancer: past, present and future.Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk virusesOverexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinomaTowards incorporating epigenetic mechanisms into carcinogen identification and evaluation.The papillomavirus E7 proteins.Association Between HIF-1 Alpha Gene Polymorphisms and Response in Patients Undergoing Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer.Epigenetics of human papillomaviruses.Validation of an HPV16-mediated carcinogenesis mouse model.Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis.Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancermicroRNAs are biomarkers of oncogenic human papillomavirus infections.Epigenetics and cervical cancer: from pathogenesis to therapy.Role of autophagy in head and neck cancer and therapeutic resistance.Exploring the therapeutic rationale for angiogenesis blockade in cervical cancerMetabolic reprogramming: a hallmark of viral oncogenesis.Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells.Human papillomavirus type 16 E7 oncoprotein upregulates the retinoic acid receptor-beta expression in cervical cancer cell lines and K14E7 transgenic mice.The human papillomavirus E7 oncoprotein as a regulator of transcription.A compendium of proteins that interact with HIF-1α.Regulation of the human papillomavirus type 16 late promoter by transcriptional elongation.The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer.
P2860
Q28086919-17C621B0-BA48-46AC-B00E-BFFE95606BF8Q33566222-CDB96396-8D5D-48BD-A025-2192A71B840CQ33699410-14BF89A5-7B83-4B2F-8171-F443E777A4B7Q33774265-7F88C557-A4F5-42BB-A4EA-BCA6CABF07BCQ34057826-526B053C-62FD-4C31-80EC-F1277313554EQ35192650-893E9DC4-B06E-462D-B518-153C4B809D14Q35192986-90716815-0CF2-4202-A5A8-4D10F690A757Q35245080-7F6ADD1C-C314-4ED8-9F1D-4B27A4A3F4FBQ35382611-862AC0B4-0623-4F91-8E2A-4F30F948CE7DQ35541384-81329E7A-2AC4-4930-A749-CA0C5CC72382Q35602354-37F143C8-AAF7-4159-9DFE-D50407CDEC07Q35673572-EE1915E8-F3E9-4747-BC1C-DC954B7D5C37Q35738843-399C1884-B3A8-4044-9558-69EF77569556Q35876828-A8ECBC1A-2581-4293-ADF8-9DE618703691Q36414554-81153DB6-34C9-4FA4-83B5-26E3812C3D7EQ36884393-525A6781-99B5-45D7-BDEA-20D9354EC1F6Q36937771-F124380E-6BF3-45AE-97F9-2E09651149F6Q36989890-D850C0A0-3614-4B73-9733-234053FF193DQ37062452-982E8C53-AF5C-4483-BBFE-375FCB3BB26BQ37151661-8F2CF966-7F34-46CB-A99A-FF359D9ABE6FQ37198662-C1A777E6-2F45-469E-8217-F07BFA41EAAFQ37252269-985845DB-7BE6-4317-BA45-2C0942785A43Q37293605-CA07031E-22A1-462D-ADEA-4161C4FF5DA5Q37558791-1EDA219A-8646-4FE1-9088-F7DB25F44224Q37568629-77C54334-4F1F-4556-85CC-504FA3B311A2Q37594412-4BEC31B6-7872-4492-928B-D34D79E15114Q37659973-9CF48A64-EC9E-4615-9C8A-A0F8311FC689Q38189740-D8319040-507E-4A3F-AEAA-9EEED072D574Q38209432-03813818-9171-43EF-88E1-F8EBED349EB5Q38319730-CF81EEF8-194F-423C-9C4A-35BBCB81D2B7Q38674284-2D5F543F-1555-4276-A74F-B1D465075EC6Q38723429-64853503-B76D-482D-BD3C-BC266AF455DBQ38725533-2CA855C6-5021-4521-B3D8-36BBFC725A1BQ38824314-F6CE3316-EB27-4753-822D-A75EDD635016Q38853165-55FACEB0-7EFD-44F4-8F51-5230B154A903Q39000409-F637C92F-5534-41E6-8D31-C78F4672AB54Q39197245-E6B70C11-8419-4689-A223-5413C99AF7AAQ40225247-2E39DC02-6AE8-4D2B-B7DA-5E7946138FAEQ40444191-2D80DA08-802A-4E45-BC10-602688BBF8C5Q47097175-1F602687-A099-4260-A653-25D4FDD78EE2
P2860
Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human papillomavirus E7 enhanc ...... inding of histone deacetylases
@ast
Human papillomavirus E7 enhanc ...... inding of histone deacetylases
@en
Human papillomavirus E7 enhanc ...... inding of histone deacetylases
@nl
type
label
Human papillomavirus E7 enhanc ...... inding of histone deacetylases
@ast
Human papillomavirus E7 enhanc ...... inding of histone deacetylases
@en
Human papillomavirus E7 enhanc ...... inding of histone deacetylases
@nl
prefLabel
Human papillomavirus E7 enhanc ...... inding of histone deacetylases
@ast
Human papillomavirus E7 enhanc ...... inding of histone deacetylases
@en
Human papillomavirus E7 enhanc ...... inding of histone deacetylases
@nl
P2860
P1433
P1476
Human papillomavirus E7 enhanc ...... inding of histone deacetylases
@en
P2093
Kavi P M Mehta
Laimonis A Laimins
P2860
P304
P356
10.1158/0008-5472.CAN-10-2626
P407
P577
2010-12-08T00:00:00Z